Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy.
J Pain Symptom Manage. 2021 Mar;61(3):571-578.e1. doi: 10.1016/j.jpainsymman.2020.10.008. Epub 2020 Oct 13.
The Cancer Dyspnea Scale (CDS) is a self-reported multidimensional tool used for the assessment of dyspnea, a subjective experience of breathing discomfort, in patients with cancer. The scale describes dyspnea using three distinct factors: physical, psychological, and discomfort at rest.
To crossculturally validate the Italian version of CDS (CDS-IT) and examine its content validity, feasibility, internal consistency, and construct validity in patients with advanced cancer.
A cross-sectional study was conducted. CDS-IT was forward-backward translated, and its content was validated among a group of experts. Cronbach's α coefficients were used to assess the internal consistency. Construct validity was examined in terms of structural validity through confirmatory factor analysis, and convergent validity was examined with Visual Analogue Scale Dyspnea through the Pearson's correlation coefficient (r). Cancer Quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care) and Italian Palliative Outcome Scale were also tested.
The CDS-IT was crossculturally validated and showed satisfactory content validity. A total of 101 patients (mean age = 76 [SD = 12]; 53% females) were recruited in palliative care settings. CDS-IT reported a good internal consistency in the total score and its factors (α = 0.74-0.83). The factor analysis corresponded acceptably but not completely with the original study. CDS-IT strongly correlated with Visual Analogue Scale Dyspnea (r = 0.68) and moderately with Italian Palliative Outcome Scale and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care (r = 0.33-0.36, respectively).
The study findings supported the crosscultural validity of the CDS-IT. Its feasibility, internal consistency, and construct validity are satisfactory for clinical practice. The CDS-IT is available to health care professionals as a useful tool to assess dyspnea in patients with cancer.
癌症呼吸困难量表(CDS)是一种自我报告的多维工具,用于评估癌症患者的呼吸困难,这是一种主观的呼吸不适体验。该量表使用三个不同的因素来描述呼吸困难:身体、心理和休息时的不适。
对意大利版 CDS(CDS-IT)进行跨文化验证,并在晚期癌症患者中检查其内容效度、可行性、内部一致性和结构效度。
进行了一项横断面研究。CDS-IT 进行了前后翻译,并由一组专家对其内容进行了验证。使用克朗巴赫α系数评估内部一致性。结构效度通过验证性因子分析进行检验,通过皮尔逊相关系数(r)检验与视觉模拟量表呼吸困难的收敛效度。还测试了癌症生活质量(欧洲癌症研究与治疗组织生活质量问卷核心 15 个姑息治疗)和意大利姑息治疗结局量表。
CDS-IT 经过跨文化验证,具有令人满意的内容效度。共纳入姑息治疗环境下的 101 例患者(平均年龄 76 [标准差 12];53%为女性)。CDS-IT 总分及其各因子的内部一致性较好(α=0.74-0.83)。因子分析与原始研究基本相符,但不完全相符。CDS-IT 与视觉模拟量表呼吸困难强烈相关(r=0.68),与意大利姑息治疗结局量表和欧洲癌症研究与治疗组织生活质量问卷核心 15 个姑息治疗中度相关(r=0.33-0.36)。
研究结果支持 CDS-IT 的跨文化有效性。其可行性、内部一致性和结构效度在临床实践中令人满意。CDS-IT 为医疗保健专业人员提供了一种评估癌症患者呼吸困难的有用工具。